08.06.2012 • News

Prisca Havranek-Kosicek, Ph.D., New Chief Financial Officer of DSM Pharmaceutical Products

Dr. Havranek-Kosicek, previously Director of Finance and Control for the DSM Pharma Chemicals business unit of DSM Pharmaceutical Products, the pharmaceutical contract manufacturing and technology organization of Royal DSM has been appointed CFO of the entire business group.

Dr. Havranek-Kosicek will report to Alexander R. Wessels, President and Chief Executive Officer of DSM Pharmaceutical Products.

 

Prior to joining DSM, Ms. Havranek-Kosicek held executive positions in financial control at Immofinanz, and was Managing Director of AUA Beteiligungen and VicePresident Corporate Subsidiaries and Investor Relations at Austrian Airlines.

 

 

 

 

 

 

 

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.